Eyepoint Pharmaceuticals Inc (EYPT)

04:59 AM

How EyePoint Pharmaceuticals Inc. (PV3B) stock responds to job market shiftsMarket Growth Review & Community Consensus Trade Signals - Newser

04:59 AM

04:45 AM

Can EyePoint Pharmaceuticals Inc. (PV3B) stock deliver strong annual returnsWeekly Trading Summary & Real-Time Volume Trigger Notifications - Newser

04:45 AM

04:28 AM

How buyback programs support EyePoint Pharmaceuticals Inc. (PV3B) stockMarket Risk Report & Smart Investment Allocation Tips - Newser

04:28 AM

02:20 AM

Will EyePoint Pharmaceuticals Inc. stock outperform value stocksQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - Newser

02:20 AM

Dec 04, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at 15.0 USD - Investing.com

Dec 04, 2025

Dec 04, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at 15.0 USD By Investing.com - Investing.com Nigeria

Dec 04, 2025

Dec 04, 2025

Will EyePoint Pharmaceuticals Inc. (PV3B) stock outperform energy sector in 2025CPI Data & Weekly Return Optimization Plans - Newser

Dec 04, 2025

Dec 02, 2025

Is EyePoint Pharmaceuticals Inc. (PV3B) stock positioned for secular growthWeekly Earnings Recap & Fast Entry Momentum Alerts - Newser

Dec 02, 2025

Dec 01, 2025

EyePoint Pharmaceuticals: Promising Outlook for Duravyu in Wet AMD Treatment and Strategic Growth Potential - TipRanks

Dec 01, 2025

Dec 01, 2025

EyePoint Pharmaceuticals Director Sells Shares - TradingView

Dec 01, 2025

Nov 30, 2025

XTX Topco Ltd Acquires 94,210 Shares of Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat

Nov 30, 2025

Nov 29, 2025

What drives EyePoint Pharmaceuticals Inc stock priceEvening Star Patterns & Exceptional Return Capital - earlytimes.in

Nov 29, 2025

Nov 28, 2025

Investors Appear Satisfied With EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Prospects As Shares Rocket 26% - 富途牛牛

Nov 28, 2025

Nov 28, 2025

EyePoint Pharmaceuticals (EYPT) Is Up 8.4% After Positive Phase 3 Safety Review for DURAVYU - Sahm

Nov 28, 2025

Nov 28, 2025

Officer/Dir Lurker Files To Sell 500 Of EyePoint Pharmaceuticals Inc [EYPT] - TradingView

Nov 28, 2025

Nov 28, 2025

What analysts say about EyePoint Pharmaceuticals Inc PV3B stockHigh Dividend Yield Stocks & Access Free Risk Analysis Before You Invest - earlytimes.in

Nov 28, 2025

Nov 28, 2025

Avoiding Lag: Real-Time Signals in (EYPT) Movement - news.stocktradersdaily.com

Nov 28, 2025

Nov 27, 2025

EyePoint Pharmaceuticals (EYPT): A Fresh Valuation Look Following Key DURAVYU Phase 3 Safety Review Completion - Sahm

Nov 27, 2025

Nov 27, 2025

Will EyePoint Pharmaceuticals Inc. stock see PE expansionJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at $14.94 By Investing.com - Investing.com Nigeria

Nov 26, 2025

Nov 26, 2025

Eyepoint Pharmaceuticals stock hits 52-week high at $14.94 - Investing.com

Nov 26, 2025

Nov 26, 2025

EyePoint receives second consecutive positive recommendation from DSMC - Modern Retina

Nov 26, 2025

Nov 21, 2025

Why Institutions Believe Infibeam Avenues Limited Is Undervalued TodayStock Watchlist Updates & Collaborate and Win Together - earlytimes.in

Nov 21, 2025

Nov 21, 2025

EyePoint Pharmaceuticals (EYPT) Clears Phase 3 Safety Hurdle for DURAVYU—Is a New Wet AMD Era Ahead? - Sahm

Nov 21, 2025

Nov 21, 2025

Can EyePoint Pharmaceuticals Inc. (PV3B) stock sustain double digit ROETrade Risk Report & Detailed Earnings Play Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

EyePoint Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Australia

Nov 21, 2025

Nov 20, 2025

EyePoint Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com

Nov 20, 2025

Nov 20, 2025

Will EyePoint Pharmaceuticals Inc. (PV3B) stock beat growth indexesExit Point & Daily Technical Forecast Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Is EyePoint Pharmaceuticals Inc. (PV3B) stock trading at attractive multiplesEarnings Risk Summary & Smart Swing Trading Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Is EyePoint Pharmaceuticals Inc. stock attractive for passive investorsJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com

Nov 20, 2025

Nov 20, 2025

Why ETFs are accumulating EyePoint Pharmaceuticals Inc. (PV3B) stock2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com

Nov 20, 2025

Nov 20, 2025

What margin trends mean for EyePoint Pharmaceuticals Inc. stockForecast Cut & Daily Technical Forecast Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Will EyePoint Pharmaceuticals Inc. (PV3B) stock hit Wall Street targetsQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

EyePoint Pharmaceuticals (EYPT): Valuation Update Following Positive Phase 3 DURAVYU Safety Review - Yahoo Finance

Nov 19, 2025

Nov 19, 2025

How EyePoint Pharmaceuticals Inc. stock performs in high volatility marketsGold Moves & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Is EyePoint Pharmaceuticals Inc. stock ready for breakout2025 Bull vs Bear & Real-Time Volume Analysis - newser.com

Nov 19, 2025